3 Pharmaceutical Stocks to Sell Now

Advertisement

The overall ratings of three pharmaceutical stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

Alimera Sciences, Inc. (ALIM) is on the decline this week, earning a D (“sell”) after receiving a C (“hold”) last week. Alimera Sciences engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. ALIM also rates an F in Portfolio Grader’s specific subcategory of Cash Flow. To get an in-depth look at ALIM, get Portfolio Grader’s complete analysis of ALIM stock.

Perrigo Co. Plc (PRGO) is having a tough week. The company’s rating falls from a C to a D. The Perrigo manufactures, distributes and markets pharmaceutical and nutritional products. The stock currently has a trailing PE Ratio of 116.80. For more information, get Portfolio Grader’s complete analysis of PRGO stock.

Theravance Biopharma Inc (TBPH) ratings are on the decline this week as the company earns an F (“strong sell”). Last week, it received a D (“sell”). The stock gets F’s in Equity and Cash Flow. As of June 26, 2015, 11.1% of outstanding Theravance Biopharma Inc shares were held short. To get an in-depth look at TBPH, get Portfolio Grader’s complete analysis of TBPH stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/06/3-pharmaceutical-stocks-to-sell-now-alim-prgo-tbph-2/.

©2024 InvestorPlace Media, LLC